UNAUDITED PRO FORMA COMBINED CONSOLIDATED FINANCIAL STATEMENTS

Exhibit: 99.6

UNAUDITED PRO FORMA COMBINED CONSOLIDATED FINANCIAL STATEMENTS

Merger with Wellesley Bancorp, Inc.

On December 5, 2019, Cambridge Bancorp, a Massachusetts corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, Cambridge Trust Company, the Company’s subsidiary bank (“Cambridge Trust”), Wellesley Bancorp, Inc. (“Wellesley”), and Wellesley Bank, Wellesley’s subsidiary bank (“Wellesley Bank”), pursuant to which Wellesley will merge with and into the Company and Wellesley Bank will merge with and into Cambridge Trust, with the Company and Cambridge Trust as the surviving entities (collectively, the “Mergers”). As a result of the Mergers, each share of Wellesley common stock will be exchanged for 0.580 shares of the Company’s common stock.

The following unaudited pro forma combined consolidated financial statements have been prepared in accordance with Article 11 of Regulation S-X and combine the historical consolidated financial position and results of operations of the Company and its subsidiaries and Wellesley as an acquisition by the Company of Wellesley using the acquisition method of accounting and giving effect to the related pro forma adjustments described in the accompanying notes. Under the acquisition method of accounting, the assets and liabilities of Wellesley were recorded by the Company at their respective fair values as of the date the Mergers were completed. Certain reclassifications were made to Wellesley’s historical financial information to conform to the Company’s presentation of financial information. All significant pro forma adjustments and underlying assumptions are described in the accompanying notes. The unaudited pro forma combined consolidated statements of income give effect to the Mergers as if they occurred on January 1, 2018. The unaudited pro forma combined consolidated balance sheet gives effect to the Mergers as if they occurred on September 30, 2019. The unaudited pro forma combined financial statements should be read in conjunction with: the Company’s audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2018, which were included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and the Company’s unaudited financial statements and the related notes thereto as of and for the nine months ended September 30, 2019, which were included in the Company’s Quarterly Report on Form 10-Q for the nine months ended September 30, 2019, which were filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 18, 2019, and November 7, 2019, respectively, and Wellesley’s audited consolidated financial statements as of and for the year ended December 31, 2018 and 2017 and Wellesley unaudited consolidated financial statements as of and for the nine months ended September 30, 2019, which are being filed as Exhibit 99.4 and Exhibit 99.5 to this Current Report on Form 8-K, respectively.

The unaudited pro forma combined consolidated financial statements are presented for illustrative purposes only, do not indicate the actual financial results of the combined company had the Mergers occurred on January 1, 2018 at the beginning of each period presented, nor are they indicative of the Company’s future financial position or financial results.

Merger with Optima Bank & Trust Company

On April 17, 2019, the Company, completed its previously announced acquisition of Optima Bank & Trust Company (“Optima”), pursuant to an Agreement and Plan of Merger, dated as of December 5, 2018 (the “Optima Merger Agreement”), by and between Cambridge, Cambridge Trust Company and Optima. Under the terms of the Optima Merger Agreement, Optima merged with and into Cambridge Trust Company (the “Optima Merger”), with Cambridge Trust Company being the surviving entity. As a result of the Optima Merger, each share of Optima common stock was exchanged for either (i) 0.3468 shares of Cambridge common stock, (ii) $32.00 in cash, or (iii) a combination of the two, subject to customary pro ration procedures, which resulted in an aggregated stock / cash consideration mix of 95 percent / 5 percent.

The following unaudited pro forma combined consolidated financial statements have been prepared in accordance with Article 11 of Regulation S-X and combine the historical consolidated financial position and results of operations of Cambridge and its subsidiaries and Optima as an acquisition by Cambridge of Optima using the acquisition method of accounting and giving effect to the related pro forma adjustments described in the accompanying notes. Under the acquisition method of accounting, the assets and liabilities of Optima were recorded by Cambridge at their respective fair values as of the date the Optima Merger was completed. Certain reclassifications were made to Optima’s historical financial information to conform to Cambridge’s presentation of financial information. All significant pro forma adjustments and underlying assumptions are described in the accompanying notes. The unaudited pro forma combined consolidated statements of income give effect to the Optima Merger as if it occurred on January 1, 2018. The unaudited pro forma combined consolidated balance sheet gives effect to the Optima Merger as if it occurred on September 30, 2019. The unaudited pro forma combined financial statements should be read in conjunction with: Cambridge’s audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2018, which were included in Cambridge’s Annual Report on Form 10-K for the year ended December 31, 2018, and Cambridge’s unaudited financial statements and the related notes thereto as of and for the six months ended June 30, 2019, which were included in Cambridge’s Quarterly Report on Form 10-Q for the six months ended June 30, 2019, which were filed with the SEC on March 18, 2019, and August 8, 2019, respectively and Optima’s audited financial statements as of and for the year ended December 31, 2018 and 2017 and Xxxxxx’s unaudited condensed financial statements as of and for the three months ended March 31, 2019, which were filed with the SEC on October 22, 2019 as Exhibits 99.1 and 99.2, respectively, to the Company’s Current Report on Form 8-K.

*                    *                     *

The unaudited pro forma shareholders’ equity and net income are qualified by the statements set forth under this caption and should not be considered indicative of the market value of the Company common stock or the actual or future results of operations of the Company for any period. Actual results may be materially different than the pro forma information presented.

UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEETS

		September 30, 2019
		Cambridge (as Reported)				Wellesley (as Reported)				Adjustments for Cambridge’s Acquisition of Wellesley				Cambridge (Pro Forma with Wellesley)				Adjustments for Capital Raise				Cambridge (Pro Forma with Wellesley and Capital Raise)
		(dollars in thousands, except par value)
Assets
Cash and cash equivalents		$	68,949			$	81,353			$	(15,128	)(1)		$	135,174			$	33,250	(12)		$	168,424
Investment securities
Available for sale, at fair value			148,068				33,793				288	(2)			182,149				—				182,149
Held to maturity, at amortized cost			269,475				100				—				269,575				—				269,575
Total investment securities			417,543				33,893				288				451,724				—				451,724
Loans held for sale, at lower of cost or fair value			2,082				6,351				—				8,433				—				8,433
Loans			2,179,882				832,803				(10,351	)(3)			3,002,334				—				3,002,334
Less: allowance for loan losses			(18,035	)			(7,218	)			7,218	(4)			(18,035	)			—				(18,035	)
Net loans			2,161,847				825,585				(3,133	)			2,984,299				—				2,984,299
Federal Home Loan Bank of Boston Stock, at cost			9,159				6,162				—				15,321				—				15,321
Bank owned life insurance			37,161				7,946				—				45,107				—				45,107
Banking premises and equipment, net			14,954				3,785				—				18,739				—				18,739
Right-of-use asset, operating leases			34,553				6,852				—				41,405				—				41,405
Deferred income taxes, net			7,939				2,717				(798	)(5)			9,858				—				9,858
Accrued interest receivable			6,959				2,769				—				9,728				—				9,728
Goodwill			31,206				—				44,883	(6)			76,089				—				76,089
Merger related intangibles			3,429				—				6,930	(7)			10,359				—				10,359
Other assets			46,087				8,454				—				54,541				—				54,541
Total assets		$	2,841,868			$	985,867			$	33,042			$	3,860,777			$	33,250			$	3,894,027
Liabilities
Deposits
Demand		$	654,133			$	133,187			$	—			$	787,320			$	—			$	787,320
Interest bearing checking			429,755				42,162				—				471,917				—				471,917
Money market			214,721				280,434				—				495,155				—				495,155
Savings			876,392				72,807				—				949,199				—				949,199
Certificates of deposit			232,858				230,155				671	(8)			463,684				—				463,684
Total deposits			2,407,859				758,745				671				3,167,275				—				3,167,275
Short-term borrowings			113,935				51,000				—				164,935				—				164,935
Long-term borrowings			—				77,533				285	(9)			77,818				—				77,818
Subordinated debt			—				9,854				—				9,854				—				9,854
Operating lease liabilities			35,990				6,907				—				42,897				—				42,897
Other liabilities			40,739				10,043				—				50,782				—				50,782
Total liabilities			2,598,523				914,082				956				3,513,561				—				3,513,561
Shareholders’ Equity
Common stock			4,850				26				1,452	(10)			6,328				452	(12)			6,779
Additional paid-in capital			98,256				27,500				74,893	(11)			200,649				32,798	(12)			233,448
Retained earnings			142,237				44,598				(44,598	)(11)			142,237				—				142,237
Accumulated other comprehensive loss			(1,998	)			592				(592	)(11)			(1,998	)			—				(1,998	)
Unearned compensation - ESOP			—				(931	)			931	(11)			—				—				—
Total shareholders’ equity			243,345				71,785				32,086				347,216				33,250				380,466
Total liabilities and shareholders’ equity		$	2,841,868			$	985,867			$	33,042			$	3,860,777			$	33,250			$	3,894,027

Footnotes to Unaudited Pro Forma Consolidated Statements of Balance Sheets at September 30, 2019:

(1) Includes $4.8 million paid to the holders of Wellesley stock options and estimated after-tax merger expenses of $10.7 million

(2) Represents the estimated adjustment to increase investments to fair market value

(3) Represents the estimated adjustment to reduce loans to fair market value

(4) Reflects the elimination of Wellesley’s existing loan loss reserve at acquisition

(5) Represents the amount to record estimated deferred income taxes on the fair value adjustments presented, at an estimated tax rate of 25.5%

(6) Represents the preliminary estimated amount of goodwill, based on issuance of 1,477,645 CATC shares outstanding at $77.50 per share (December 3, 2019, closing price)

(7) Represents the estimated amount of the core deposit intangible asset recognized in connection with the business combination

(8) Represents the estimated amount to increase time deposits to fair market value

(9) Represents the estimated amount to increase borrowings from FHLB to fair market value

(10) Represents the amount to eliminate Wellesley common stock at par and record the estimated par value of shares issued by Cambridge

(11) Represents the amount to eliminate Wellesley equity accounts and record the estimated additional paid-in capital

(12) Represents the amount to record the issuance of 451,612 CATC shares at $77.50 per share (December 3, 2019, closing price), less estimated issuance costs of $1.8 million

UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF INCOME

		For the Nine Months Ended September 30, 2019
		Cambridge (as Reported)				Optima (through April 17, 2019)				Adjustments for Cambridge’s Acquisition of Optima				Cambridge (Pro Forma with Optima)				Wellesley (as Reported)				Adjustments for Cambridge’s Acquisition of Wellesley				Cambridge (Pro Forma with Wellesley)				Cambridge (Pro Forma with Wellesley and Capital Raise)
		(dollars in thousands, except share data)
Interest and dividend income
Interest on taxable loans		$	60,919			$	6,050			$	591	(1)		$	67,560			$	27,867			$	687	(8)		$	96,114			$	96,114
Interest on tax-exempt loans			385				30				—				415				73				—				488				488
Interest on taxable investment securities			6,074				155				—				6,229				1,076				(49	)(9)			7,256				7,256
Interest on tax-exempt investment securities			1,709				—				—				1,709				238				—				1,947				1,947
Dividends on FHLB of Boston stock			281				18				—				299				213				—				512				512
Interest on overnight investments			556				196				—				752				577				—				1,329				1,329
Total interest and dividend income			69,924				6,449				591				76,964				30,044				638				107,646				107,646
Interest expense
Interest on deposits			11,489				1,941				63	(2)			13,493				7,665				(535	)(10)			20,623				20,623
Interest on borrowed funds			1,347				195				—				1,542				2,328				(226	)(11)			3,644				3,644
Total interest expense			12,836				2,136				63				15,035				9,993				(761	)			24,267				24,267
Net interest and dividend income			57,088				4,313				528				61,929				20,051				1,399				83,379				83,379
Provision for Loan Losses			2,673				70				—				2,743				480				—				3,223				3,223
Net interest and dividend income after provision for loan losses			54,415				4,243				528				59,186				19,571				1,399				80,156				80,156
Noninterest income
Wealth management revenue			19,576				—				—				19,576				1,228				—				20,804				20,804
Deposit account fees			2,395				69				—				2,464				74				—				2,538				2,538
ATM/Debit card income			1,046				99				—				1,145				57				—				1,202				1,202
Bank owned life insurance income			454				36				—				490				177				—				667				667
Gain (loss) on disposition of investment securities			(79	)			—				—				(79	)			8				—				(71	)			(71	)
Gain on loans held for sale			491				47				—				538				161				—				699				699
Loan related derivative income			1,571				—				—				1,571				771				—				2,342				2,342
Other income			1,014				53				—				1,067				50				—				1,117				1,117
Total noninterest income			26,468				304				—				26,772				2,526				—				29,298				29,298
Noninterest expense
Salaries and employee benefits			34,353				2,238				—				36,591				9,214				—				45,805				45,805
Occupancy and equipment			7,813				678				18	(3)			8,509				2,466				—				10,975				10,975
Data processing			4,532				216				—				4,748				930				—				5,678				5,678
Professional services			2,411				414				—				2,825				637				—				3,462				3,462
Marketing			1,175				94				—				1,269				197				—				1,466				1,466
FDIC Insurance			369				4				—				373				336				—				709				709
Merger expenses			3,880				3,381				(7,261	)(4)			—				—				—				—				—
Other expenses			2,216				195				120	(5)			2,531				1,674				945	(12)			5,150				5,150
Total noninterest expense			56,749				7,220				(7,123	)			56,846				15,454				945				73,245				73,245
Income before income taxes			24,134				(2,673	)			7,651				29,112				6,643				454				36,209				36,209
Income tax expense (benefit)			5,988				(570	)			1,836	(6)			7,254				1,800				116	(13)			9,170				9,170
Net income		$	18,146				(2,103	)			5,815			$	21,858			$	4,843			$	338			$	27,039			$	27,039
Share data:
Weighted average number of shares outstanding, basic			4,525,178				2,192,588				—				4,948,444	(7)			2,454,103				—				6,426,088	(14)			6,877,701	(15)
Weighted average number of shares outstanding, diluted			4,552,092				2,325,417				—				4,975,358	(7)			2,545,786				—				6,453,002	(14)			6,904,615	(15)
Basic earnings per share		$	3.98			$	(0.96	)		$	—			$	4.42			$	1.97			$	—			$	4.21			$	3.93
Diluted earnings per share		$	3.95			$	(0.90	)		$	—			$	4.39			$	1.91			$	—			$	4.19			$	3.92

Footnotes to Unaudited Pro Forma Consolidated Statements of Income for the Nine Months Ended September 30, 2019:

Notes for Merger with Optima:

(1) Represents accretion income as a result of the fair market value adjustment on loans of $6.3 million

(2) Represents amortization expense as a result of the fair market value adjustment on Certificates of Deposit of $472,000

(3) Represents the depreciation as a result of the fair market value adjustment for fixed assets of $980,000

(4) Represents the elimination of merger expenses in connection with the Optima merger

(5) Represents the amortization expense as a result of the recognition of the core deposit intangible asset of $3.6 million

(6) Represents the Income tax effect of pro forma adjustments utilizing an effective tax rate of 24%

(7) Pro forma weighted average shares include 722,746 shares issued to former Optima shareholders

Notes for Merger with Wellesley:

(8) Represents accretion income as a result of the fair market value adjustment on loans of $10.4 million

(9) Represents amortization expense as a result of the fair market value adjustment on Investment Securities of $288,000

(10) Represents accretion income as a result of the fair market value adjustment on Certificates of Deposit of $671,000

(11) Represents accretion income as a result of the fair market value adjustment on Federal Home Loan Bank borrowings of $285,000

(12) Represents the amortization expense as a result of the recognition of the core deposit intangible asset of $6.9 million

(13) Represents the Income tax effect of pro forma adjustments utilizing an effective tax rate of 25.5%

(14) Pro forma weighted average shares include 1,477,645 shares to be issued to former Wellesley shareholders

(15) Pro forma weighted average shares include 451,612 shares to be issued in connection with the capital raise

UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF INCOME

		For the Year Ended December 31, 2018
		(dollars in thousands, except share data)
		Cambridge (as Reported)				Optima (as Reported)				Adjustments for Cambridge’s Acquisition of Optima				Cambridge (Pro Forma with Optima)				Wellesley (as Reported)				Adjustments for Cambridge’s Acquisition of Wellesley				Cambridge (Pro Forma with Wellesley)				Cambridge (Pro Forma with Wellesley and Capital Raise)
		(dollars in thousands, except share data)
Interest and dividend income
Interest on taxable loans		$	57,941			$	19,604			$	2,038	(1)		$	79,583			$	30,927			$	874	(8)		$	111,384			$	111,384
Interest on tax-exempt loans			371				30				—				401				101				—				502				502
Interest on taxable investment securities			7,457				580				—				8,037				1,441				(65	)(9)			9,413				9,413
Interest on tax-exempt investment securities			2,404				15				—				2,419				327				—				2,746				2,746
Dividends on FHLB of Boston stock			287				56				—				343				333				—				676				676
Interest on overnight investments			595				263				—				858				509				—				1,367				1,367
Total interest and dividend income			69,055				20,548				2,038				91,641				33,638				809				126,088				126,088
Interest expense
Interest on deposits			5,023				5,949			$	253	(2)			11,225				6,442				(652	)(10)			17,015				17,015
Interest on borrowed funds			444				3				—				447				2,467				(243	)(11)			2,671				2,671
Total interest expense			5,467				5,952				253				11,672				8,909				(895	)			19,686				19,686
Net interest and dividend income			63,588				14,596				1,785				79,969				24,729				1,704				106,402				106,402
Provision for Loan Losses			1,502				246				—				1,748				585				—				2,333				2,333
Net interest and dividend income after provision for loan losses			62,086				14,350				1,785				78,221				24,144				1,704				104,069				104,069
Noninterest income
Wealth management revenue			25,191				—				—				25,191				1,616				—				26,807				26,807
Deposit account fees			3,071				245				—				3,316				87				—				3,403				3,403
ATM/Debit card income			1,180				344				—				1,524				89				—				1,613				1,613
Bank owned life insurance income			526				153				—				679				234				—				913				913
Gain (loss) on disposition of investment securities			2				22				—				24				—				—				24				24
Gain on loans held for sale			99				206				—				305				64				—				369				369
Loan related derivative income			1,651				—				—				1,651				340				—				1,991				1,991
Other income			1,269				335				—				1,604				156				—				1,760				1,760
Total noninterest income			32,989				1,305				—				34,294				2,586				—				36,880				36,880
Noninterest expense
Salaries and employee benefits			41,212				7,104				—				48,316				10,842				—				59,158				59,158
Occupancy and equipment			9,072				2,185				54	(3)			11,311				3,004				—				14,315				14,315
Data processing			5,177				552				—				5,729				990				—				6,719				6,719
Professional services			3,258				959				—				4,217				766				—				4,983				4,983
Marketing			2,229				305				—				2,534				323				—				2,857				2,857
FDIC Insurance			574				495				—				1,069				626				—				1,695				1,695
Merger expenses			201				—				(201	)(4)			—				—				—				—				—
Other expenses			2,264				477				360	(5)			3,101				2,012				1,260	(12)			6,373				6,373
Total noninterest expense			63,987				12,077				213				76,277				18,563				1,260				96,100				96,100
Income before income taxes			31,088				3,578				1,572				36,238				8,167				444				44,849				44,849
Income tax expense			7,207				1,002				377	(6)			8,586				2,176				113	(13)			10,875				10,875
Net income		$	23,881				2,576				1,195			$	27,652			$	5,991			$	331			$	33,974			$	33,974
Share data:
Weighted average number of shares outstanding, basic			4,061,529				2,069,880				—				4,784,275	(7)			2,404,371				—				6,261,920	(14)			6,713,532	(15)
Weighted average number of shares outstanding, diluted			4,098,633				2,331,569				—				4,821,379	(7)			2,502,784				—				6,299,024	(14)			6,750,636	(15)
Basic earnings per share		$	5.82			$	1.24			$	—			$	5.78			$	2.49			$	—			$	5.43			$	5.06
Diluted earnings per share		$	5.77			$	1.10			$	—			$	5.74			$	2.40			$	—			$	5.39			$	5.03

Footnotes to Unaudited Pro Forma Consolidated Statements of Income for the Year Ended December 31, 2018:

Notes for Merger with Optima:    

(1) Represents accretion income as a result of the fair market value adjustment on loans of $6.3 million

(2) Represents amortization expense as a result of the fair market value adjustment on Certificates of Deposit of $472,000

(3) Represents the depreciation as a result of the fair market value adjustment for fixed assets of $980,000

(4) Represents the elimination of merger expenses in connection with the Optima merger

(5) Represents the amortization expense as a result of the recognition of the core deposit intangible asset of $3.6 million

(6) Represents the Income tax effect of pro forma adjustments utilizing an effective tax rate of 24%

(7) Pro forma weighted average shares include 722,746 shares issued to former Optima shareholders

Notes for Merger with Xxxxxxxxx:    

(8) Represents accretion income as a result of the fair market value adjustment on loans of $10.4 million

(9) Represents amortization expense as a result of the fair market value adjustment on Investment Securities of $288,000

(10) Represents accretion income as a result of the fair market value adjustment on Certificates of Deposit of $671,000

(11) Represents accretion income as a result of the fair market value adjustment on Federal Home Loan Bank borrowings of $285,000

(12) Represents the amortization expense as a result of the recognition of the core deposit intangible asset of $6.9 million

(13) Represents the Income tax effect of pro forma adjustments utilizing an effective tax rate of 25.5%

(14) Pro forma weighted average shares include 1,477,645 shares to be issued to former Wellesley shareholders

(15) Pro forma weighted average shares include 451,612 shares to be issued in connection with the capital raise

Preliminary Purchase Price Allocation

The pro forma adjustments include the accounting entries to record the merger transaction under the acquisition method of accounting for business combinations. The excess of the purchase price over the fair value of net assets acquired was allocated to goodwill and other intangible assets. Fair value adjustments included in the pro forma financial statements are based upon available information and certain assumptions which are considered reasonable, and will be revised as additional information becomes available.

The pro forma purchase price for the Wellesley merger is as follows (dollars in thousands):

Purchase Price Calculation
Shares outstanding			2,570
ESOP plan termination			(22	)
Shares outstanding			2,548
Shares exchanged for stock			2,548
Stock value		$	44.95
Aggregate value of shares receiving stock		$	114,533
Aggregate value to option holders		$	4,466
Aggregate Purchase Price		$	118,999
Preliminary pro forma goodwill
Fair value of assets acquired:
Cash and cash equivalents		$	81,353
Investments available for sale			34,181
Loans held for sale			6,351
Loans, net			822,452
Other assets			37,887
Core deposit intangible			6,930
Total assets acquired		$	989,154
Fair value of liabilities assumed:
Deposits			759,416
Borrowings			138,672
Other liabilities			16,950
Total liabilities assumed		$	915,038
Net assets acquired			74,116
Preliminary pro forma goodwill		$	44,883

Note 1—Basis of Presentation

The unaudited pro forma combined consolidated financial information and notes have been prepared to illustrate the effects of the Merger involving Cambridge and Optima using the acquisition method of accounting, with Cambridge treated as the acquirer, as if the Merger had been consummated January 1, 2018. The unaudited pro forma combined consolidated financial information is presented for illustrative purposes only and does not necessarily indicate the financial results of the combined companies had the companies actually been combined at the beginning of each period presented, nor does it necessarily indicate the results of operations in future periods of

the combined entity. Under the acquisition method of accounting, the assets and liabilities of Optima, as of the effective date of the Merger, were recorded by Cambridge at their respective fair values and the excess of the Merger consideration over the fair value of the net assets was allocated to goodwill and other intangible assets.

Forward-looking Statements

Certain statements herein may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements about Cambridge and its industry involve substantial risks and uncertainties. Statements other than statements of current or historical fact, including statements regarding Cambridge’s future financial condition, results of operations, business plans, liquidity, cash flows, projected costs, and the impact of any laws or regulations applicable to Cambridge, are forward-looking statements. Words such as “anticipates,” “believes,” “estimates,” “expects,” “forecasts,” “intends,” “plans,” “projects,” “may,” “will,” “should,” and other similar expressions are intended to identify these forward-looking statements. Such statements are subject to factors that could cause actual results to differ materially from anticipated results. Such factors include, but are not limited to, the following: economic conditions being less favorable than expected, disruptions to the credit and financial markets, weakness in the real estate market, legislative, regulatory or accounting changes that adversely affect Cambridge’s business and/or competitive position, the Xxxx-Xxxxx Act’s consumer protection regulations, disruptions in Cambridge’s ability to access the capital markets, changes to accounting standards and other factors that are described in Cambridge’s filings with the U.S. Securities and Exchange Commission, including Cambridge’s Annual Report on Form 10-K for the year end December 31, 2018, which Xxxxxxxxx filed on March 18, 2019. Cambridge does not undertake, and specifically disclaims any obligation, to publicly release the result of any revisions which may be made to any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements. You are cautioned not to place undue reliance on these forward-looking statements.